A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials

BACKGROUND: Safe, more efficacious treatments are needed to address the considerable morbidity and mortality associated with pulmonary tuberculosis (TB). However, the current practice in TB therapeutics trials is to use composite binary outcomes, which in the absence of standardization may inflate f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hills, N. K., Lyimo, J., Nahid, P., Savic, R. M., Lienhardt, C., Phillips, P. P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329622/
https://www.ncbi.nlm.nih.gov/pubmed/34344435
http://dx.doi.org/10.1186/s13063-021-05388-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329622/
https://www.ncbi.nlm.nih.gov/pubmed/34344435
http://dx.doi.org/10.1186/s13063-021-05388-1

Ejemplares similares